XBIO - Xenetic Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,707
1,707
1,161
436.942
17.066
Operating Expense
8,425
8,425
6,907
5,131
9,621
Operating Income
-6,718
-6,718
-5,747
-4,695
-9,603
Net Non Operating Interest Income Expense
167.152
167.152
100.467
126.171
108.489
Other Income Expense
-1.597
-1.597
1.119
-9,244
-3,280
Pretax Income
-6,552
-6,552
-5,645
-13,812
-12,775
Tax Provision
-
-
0
-2,919
-
Net Income Common Stockholders
-6,552
-6,552
-5,645
-10,893
-18,059
Diluted NI Available to Com Stockholders
-6,552
-6,552
-5,645
-10,893
-18,059
Basic EPS
-
-4.60
-5.50
-17.00
-63.30
Diluted EPS
-
-4.60
-5.50
-17.00
-63.30
Basic Average Shares
-
1,422
1,028
639.238
285.246
Diluted Average Shares
-
1,422
1,028
639.238
285.246
Total Operating Income as Reported
-6,718
-6,718
-5,747
-13,938
-12,887
Total Expenses
8,425
8,425
6,907
5,131
9,621
Interest Income
167.152
167.152
100.467
126.171
-
Net Interest Income
167.152
167.152
100.467
126.171
108.489
Net Income from Continuing & Discontinued Operation
-6,552
-6,552
-5,645
-10,893
-12,775
Normalized Income
-6,552
-6,552
-5,645
-3,603
-9,492
EBIT
-6,718
-6,718
-5,747
-4,695
-9,603
EBITDA
-6,691
-
-
-
-
Reconciled Depreciation
27.043
27.043
35.482
28.837
27.487
Net Income from Continuing Operation Net Minority Interest
-6,552
-6,552
-5,645
-10,893
-12,775
Total Unusual Items Excluding Goodwill
-
-
0
-9,243
-3,283
Total Unusual Items
-
-
0
-9,243
-3,283
Normalized EBITDA
-6,691
-6,691
-5,711
4,577
-6,293
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-1,953
0

Yahoo Finance Plus Essential access required.

Learn more